PPIDT00446
Drug Information
| Name | Belantamab mafodotin |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB15719 |
| Type | biotech |
| Indication | Belantamab mafodotin is indicated in the treatment of adults with relapsed or refractory multiple myeloma who have received at least 4 prior therapies including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent.[L15326] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, powder, for solution | Intravenous |
100 MG
|
| Injection, powder, lyophilized, for solution | Intravenous |
50 mg/1mL
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| target | Q02223 | TNFRSF17 | Tumor necrosis factor receptor superfamily member 17 | Homo sapiens | binder | Link |
| transporter | Q9Y6L6 | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | substrate | Link |
| transporter | Q9NPD5 | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | substrate | Link |
| transporter | P33527 | ABCC1 | Multidrug resistance-associated protein 1 | Homo sapiens | substrate | Link |
| transporter | Q92887 | ABCC2 | ATP-binding cassette sub-family C member 2 | Homo sapiens | substrate | Link |
| transporter | O15438 | ABCC3 | ATP-binding cassette sub-family C member 3 | Homo sapiens | substrate | Link |
| transporter | O95342 | ABCB11 | Bile salt export pump | Homo sapiens | substrate | Link |
| transporter | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | Homo sapiens | substrate | Link |